← Back to all trials
Completed
NCT05617352
The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study
Conditions: Esophageal Cancer
Sex: All
Ages: 18 Years – 90 Years
Enrollment: 1659
Sponsor: Yongtao Han
Location: China
Summary
To clarify the effect of Two-field or Three-field Lymphadenectomy on the survival of esophageal squamous cell carcinoma.
Eligibility Criteria
Inclusion Criteria:1. Men and women aged 18-85 years2. Histologically confirmed primary thoracic esophageal squamous cell carcinoma,3. Staging PT1b-4A, N0-3, M0 AJCC eighth edition4. Excluding lymph node dissection < 15, (meeting the guideline criteria)5. The tumor located in the lower middle thoracic.Exclusion Criteria:1. Patients with a history of previous thoracic and abdominal surgery that may affect lymphatic reflux2. Patients with distant metastasis confirmed by imaging3. Patients with obvious surgical contraindications.
Source: ClinicalTrials.gov (NCT05617352). StuddyBuddy aggregates publicly available trial information.